WHO ICTRP trial
Single dose study of SK-0348
JPRN-jRCT2071220001 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2071220001 |
|---|---|
| Public title | Single dose study of SK-0348 |
| Scientific title | A phase I study of SK-0348 in healthy adult subjects (Single dose) |
| Primary sponsor | Kenji Asano |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 1 |
| Conditions | Healthy adult subjects |
| Interventions | Step P Single transdermal administration of SK-0348 and placebo. Step 1-3 Single transdermal administration of SK-0348 or placebo with dose escalation. |
| Registration date | Jun 3, 2022 |
| Target size | 46 |
| Registry page | jrct.niph.go.jp |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: